Enterome

Enterome is a clinical-stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on our unique ability to decode the interactions between the gut microbiome and the immune system. Our unparalleled capability in identifying microbiome-driven small protein and peptide drugs enables us to develop two highly promising first-in-class drug pipelines targeting cancer and immune diseases.